Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2620 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Desktop Genetics Ltd.. (9/15/15). "Press Release: Desktop Genetics Ltd Raises £1.37M GBP ($2.15M USD) Funding". London. 2015-09-15
Abzena plc. (9/14/15). "Press Release: Acquisition of PacificGMP. Strategic Acquisition of GMP Biopharmaceutical Manufacturing Capability in the USA". Cambridge & San Diego, CA. 2015-09-14
Immunocore Ltd.. (9/9/15). "Press Release: Immunocore’s IMCgp100 Accepted for Adaptive Pathway Pilot Programme Potential for Accelerated Regulatory Approval in Europe". Oxford. 2015-09-09
Immunocore Ltd.. (9/9/15). "Press Release: Immunocore Expands Its Senior Management Team and Opens US Office". Oxford. 2015-09-09
Horizon Discovery Group plc. (9/9/15). "Press Release: Horizon Discovery Group plc and Abcam plc Sign License and Supply Agreement". Cambridge. 2015-09-09
AstraZeneca plc. (9/8/15). "Press Release: AstraZeneca to Invest £11.5 Million in New Clinical Oncology Bioinformatics Collaboration with The University of Manchester". 2015-09-08
ReViral Ltd.. (9/8/15). "Press Release: ReViral Announces US$21 Million Fundraising to Advance Clinical Development of a Novel Anti-viral Drug". London. 2015-09-08
Euronext N.V.. (9/8/15). "Press Release: New Stallergenes Greer Entity Lists Successfully on Euronext Paris". Paris. 2015-09-08
Lumora Ltd.. (9/7/15). "Press Release: Lumora Acquired by Erba Diagnostics Mannheim". Cambridgeshire, UK. 2015-09-07
Link Technologies Ltd.. (9/3/15). "Press Release: Link Strengthens Presence in Switzerland with Distribution Agreement. Link Technologies Appoints Swiss Company Chemie Brunschwig AG as First Partner in Europe". Bellshill, Scotland. 2015-09-03
Horizon Discovery Group plc. (9/3/15). "Press Release: Horizon Discovery Group plc and Redx Pharma plc Sign Cancer Research Collaboration". Cambridge, UK. 2015-09-03
Optibrium Ltd.. (9/2/15). "Press Release: Optibrium Appoints Head of North American Operations to Support Growing Demand. Appointment Marks the Opening of New Office in Cambridge, MA". Cambridge. 2015-09-02
AstraZeneca plc. (9/1/15). "Press Release: AstraZeneca and Valeant Pharmaceuticals to Partner on Brodalumab". 2015-09-01
Peak Scientific Instruments Ltd.. (9/1/15). "Press Release: Peak Introduces More Affordable Ultra High Purity Hydrogen Solution". 2015-09-01
Peak Scientific Instruments Ltd.. (9/1/15). "Press Release: Precision Series Made Available by Agilent Technologies as 3PP Generator Solution". 2015-09-01
AstraZeneca plc. (8/24/15). "Press Release: AstraZeneca and Peregrine Pharmaceuticals to Collaborate on Immuno-oncology Combination Clinical Trial". 2015-08-24
AstraZeneca plc. (8/24/15). "Press Release: AstraZeneca Appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer". 2015-08-24
Lumora Ltd.. (8/24/15). "Press Release: Lumora Sells Heat Elution Technology to Roche". Cambridgeshire. 2015-08-24
Malin Corporation plc. (8/24/15). "Press Release: Malin Completes Asset Acquisition Phase Ahead of Schedule. Two Additional Transactions Substantially Completes Asset Sourcing ". Dublin. 2015-08-24
GlaxoSmithKline plc. (8/21/15). "Press Release: GSK to Divest Ofatumumab for Auto-immune Indications to Novartis for up to $1 Billion plus Royalties". London. 2015-08-21
Celsus Therapeutics plc. (8/18/15). "Press Release: Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement". New York & London. 2015-08-18
Synpromics Ltd.. (8/14/15). "Press Release: Synpromics Announces Fundraise Completion". 2015-08-14
Blueberry Therapeutics Ltd.. (8/13/15). "Press Release: Andrew Kay Appointed Chairman of the Board at Blueberry Therapeutics". 2015-08-13
DefiniGen Ltd.. (8/11/15). "Press Release: DefiniGen Licences Lung Stem Cell Technology from University of Cambridge". Cambridge. 2015-08-11
Heptares Therapeutics Ltd.. (8/6/15). "Press Release: Heptares and AstraZeneca Enter Agreement to Develop Novel Immuno-oncology Treatments for a Range of Cancers". London & Boston, MA. 2015-08-06
Peak Scientific Instruments Ltd.. (7/31/15). "Press Release: Peak Scientific Augments Precision Zero Air Generator Line with Two New Models". 2015-07-31
Alfacyte Ltd.. (7/30/15). "Press Release: Glasgow Based Pharmaceutical Company Alfacyte Announced Today It Has Raised £350,000 in Equity and Grant Funding". Glasgow. 2015-07-30
Oxford BioTherapeutics Ltd.. (7/30/15). "Press Release: Oxford BioTherapeutics Receives $10 Million Capital Term Loan from Silicon Valley Bank". London. 2015-07-30
Immunocore Ltd.. (7/29/15). "Press Release: Immunocore Announces Fidelity’s Participation in $320M Financing". Oxford. 2015-07-29
GlaxoSmithKline plc. (7/29/15). "Press Release: Results Announcement for the Second Quarter 2015". London. 2015-07-29
Mereo BioPharma Group Ltd.. (7/29/15). "Press Release: Mereo BioPharma Announces Formal Launch of Company, Raises $118m". London. 2015-07-29
Hikma Pharmaceuticals plc. (7/28/15). "Press Release: Hikma Acquires Roxane Laboratories, Transforming Its Position in the US Generics Market". London. 2015-07-28
MRC Technology. (7/28/15). "Press Release: Georg-August-University Göttingen, Universitätsmedizin and MRC Technology Collaborate to Develop New Therapy for Neurodegenerative Diseases". London & Göttingen. 2015-07-28
BioOutsource Ltd.. (7/27/15). "Press Release: BioOutsource Opens New Facility in Glasgow". Glasgow. 2015-07-27
Glythera Ltd.. (7/27/15). "Press Release: Glythera-led Consortium Wins Industrial Biotechnology Catalyst Funding. £248,000 to Develop High-throughput Glycosylation Assay". 2015-07-27
Lamellar Biomedical Ltd.. (7/24/15). "Press Release: Lamellar Biomedical Closes £2.3 Million Investment Round". Bellshill, Glasgow. 2015-07-24
Advanced Chemistry Development, Inc. (ACD/Labs). (7/22/15). "Press Release: The Institute of Cancer Research Deploys ACD/Spectrus Processor to Manage and Streamline Processing of Analytical Data". Toronto, ON. 2015-07-22
Oxford Nanopore Technologies Ltd.. (7/21/15). "Press Release: Oxford Nanopore Announces £70 Million ($109 Million) Fundraising". 2015-07-21
Arquer Diagnostics Ltd.. (7/20/15). "Press Release: UroSens Announces Corporate Name Change and Rebranding to Arquer Diagnostics Ltd". Sunderland & Cambridge. 2015-07-20
Horizon Discovery Group plc. (7/20/15). "Press Release: Trading Update. Half Year Revenue of circa £8.6 Million". Cambridge. 2015-07-20
Immunocore Ltd.. (7/16/15). "Press Release: Immunocore Secures $320 Million (£205 Million) in Europe’s Largest Private Life Sciences Financing". Oxford. 2015-07-16
14M Genomics Ltd.. (7/14/15). "Press Release: 14M Genomics Appoints Alan Schafer as Chief Executive Officer". Cambridge. 2015-07-14
Celsus Therapeutics plc. (7/13/15). "Press Release: Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Agreement to Create Orphan Disease Company Focused on Complement C5 Inhibition". New York & London. 2015-07-13
Eikonix. (7/10/15). "Press Release: NanoHybrids Appoint Eikonix as UK Distributor for Their Gold Nanoparticles". 2015-07-10
ReNeuron Group plc. (7/10/15). "Press Release: ReNeuron Announces Proposed Placing to Raise £68.4 million and Notice of General Meeting [Not for US, CA, AU, ZA, JP, NZ, et al.]". Guildford. 2015-07-10
Faron Pharmaceuticals Oy. (9/7/15). "Press Release: Intention to Float on AIM [not for US, AU, CA, JP, ZA, IE, et al.]". Turku. 2015-07-09
Abingworth LLP. (7/7/15). "Press Release: Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners". London. 2015-07-07
MRC Technology. (7/7/15). "Press Release: MRC Technology Appoints Technology Transfer Director". 2015-07-07
Consilium Strategic Communications Ltd.. (7/2/15). "Press Release: Consilium Strategic Communications Appoints Chris Gardner as a Partner". London. 2015-07-02
Danaher Corporation. (7/1/15). "Press Release: Danaher Announces Pricing of Euro-Denominated Senior Notes Offering". Washington, DC. 2015-07-01
Immunocore Ltd.. (6/29/15). "Press Release: Immunocore and Lilly Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma". Oxford & Indianapolis, IN. 2015-06-29
Thermo Fisher Scientific Inc.. (6/25/15). "Press Release: Thermo Fisher Scientific Signs Agreement to Acquire Research Chemicals Leader Alfa Aesar". Waltham, MA. 2015-06-25
Eikonix. (6/25/15). "Press Release: The JuLI FL Live Cell Imager and Counter". Cambridge. 2015-06-25
Invenra, Inc.. (6/25/15). "Press Release: Invenra and Oxford BioTherapeutics Enter Collaboration to Discover Novel Therapeutic Antibodies Targeting Cancer". Madison, WI & Oxford. 2015-06-25
Illumina, Inc.. (6/25/15). "Press Release: Biomed Realty and Illumina Announce New Build-to-Suit Laboratory Building in Cambridge's Growing Life Science Cluster". San Diego, CA. 2015-06-25
Genomics England Ltd.. (6/19/15). "Press Release: Genomics England Announces 30 Research Topics Forming the Clinical Interpretation Partnership". 2015-06-19
MRC Technology. (6/19/15). "Press Release: Brain Inflammation Targeted in First Drug Discovery Project from £3m Dementia Consortium". 2015-06-19
TTP Group plc. (6/18/15). "Press Release: David Newble Joins TTP Labtech as New Managing Director". 2015-06-18
BioCity Scotland. (6/17/15). "Press Release: BioCity Scotland Tenant Company Biogelx Receives Significant Funding Boost to Allow Global Expansion". 2015-06-17
OBN (UK) Ltd.. (6/17/15). "Press Release: OBN Chief Executive Jon Rees to Step Down After Transformational Decade". London. 2015-06-17
Heptares Therapeutics Ltd.. (6/17/15). "Press Release: Positive Outcome of Phase 1a Study with First-Ever Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Patients with Alzheimer's Disease". London & Boston, MA. 2015-06-17
AstraZeneca plc. (6/16/15). "Press Release: AstraZeneca Appoints Pam Cheng as Executive Vice President, Operations and IT". 2015-06-16
GlaxoSmithKline plc. (6/16/15). "Press Release: GSK to Create Independent Research Institute with Goal of Radically Changing and Improving Medicines Development". 2015-06-16
University of Manchester, Manchester Cancer Research Centre. (6/16/15). "Press Release: State-of-the-art Research Centre Will Transform Cancer Treatment. A New £28.5m Research Centre that Will Transform Cancer Treatment Has Opened in Manchester". 2015-06-16
Agalimmune Ltd.. (6/15/15). "Press Release: Agalimmune Licenses Kode Biotech’s FSL Technology for Development of Cancer Immunotherapeutics. Deal Worth up to $31M USD (£21 Million GBP)". London. 2015-06-15
Nemesis Bioscience Ltd.. (6/15/15). "Press Release: Nemesis Bioscience Raises £300,000 in Seed Funding and Opens Development Facility in Wales". 2015-06-15
Almac Group Ltd.. (6/15/15). "Press Release: Almac Discovery Announce Ubiquitin Specific Protease Collaboration with Genentech". Craigavon. 2015-06-15
Verona Pharma plc. (6/12/15). "Press Release: Verona Pharma plc Secondary Listing to Provide Trading Facility on Xetra Exchange in Germany". Cardiff. 2015-06-12
Markes International Ltd.. (6/12/15). "Press Release: Markes International Launches Free Soft-EI Spectral Library". Llantrisant. 2015-06-12
MRC Technology. (6/10/15). "Press Release: MRC Technology and Peptinnovate Collaborate on Therapeutics for Bone Diseases". London & Stevenage. 2015-06-10
Abzena plc. (6/8/15). "Press Release: Results for the Year Ended 31 March 2015". Cambridge, UK. 2015-06-08
Sophia Genetics S.A.. (6/6/15). "Press Release: British Healthcare Institutions Lead the Way with Cutting Edge Genetic Analysis Technology to Better Examine Cancers and Congenital Diseases". Glasgow. 2015-06-06
Auspherix Ltd.. (6/3/15). "Press Release: Auspherix Raises £6 Million to Progress Its Novel Antibiotics and Establishes UK Operations". Stevenage. 2015-06-03
ProBioGen AG. (6/2/15). "Press Release: Anti-Ebola MVA Vaccine Produced on ProBioGen’s Avian AGE1.CR Cell Line Platform in Clinical Trials". Berlin. 2015-06-02
Teva UK Ltd.. (6/2/15). "Press Release: Teva UK Limited Names Steve Oldfield as General Manager". 2015-06-02
AstraZeneca plc. (5/29/15). "Press Release: AstraZeneca and Lilly to Collaborate on Immuno-oncology Combination Clinical Trial in Solid Tumours". 2015-05-29
Fluidigm Corporation. (5/27/15). "Press Release: Fluidigm Brings Automated Targeted Library Prep To Juno". South San Francisco, CA. 2015-05-27
One Nucleus. (5/26/15). "Press Release: One Nucleus and Wellcome Trust Sanger Institute Form Partnership". 2015-05-26
AstraZeneca plc. (5/22/15). "Press Release: AstraZeneca Provides Update on Brodalumab Development Programme". 2015-05-22
Liverpool ChiroChem Ltd.. (5/20/15). "Press Release: LCC Launches Unique Process to Reduce Production Time of Chiral Building Blocks by 75%". Liverpool. 2015-05-20
SGS S.A.. (5/19/15). "Press Release: SGS Acquires SVA Ltd, UK". 2015-05-19
PsiOxus Therapeutics Ltd.. (5/19/15). "Press Release: PsiOxus Therapeutics Raises a £25m Series C Investment to Progress Oncolytic Virus plus Checkpoint Inhibitor Combination Study in Metastatic Colorectal Cancer". Oxford, UK. 2015-05-19
Abcodia Ltd.. (5/18/15). "Press Release: Abcodia Secures Funding of £5.25 million ($8m) to Launch the ROCA Test for the Early Detection of Ovarian Cancer". 2015-05-18
Redx Pharma plc. (5/14/15). "Press Release: Launch of Third Subsidiary, Redx Immunology Limited". 2015-05-14
Xention Ltd.. (5/13/15). "Press Release: Xention Introduces Metrion Biosciences, a Specialist Ion Channel Screening Business". Cambridge. 2015-05-13
Agilent Technologies Inc.. (5/12/15). "Press Release: Agilent Technologies Presents Thought Leader Award to Lipidomics Expert Dr. Jules Griffin. Cambridge Researcher to Further Studies of Obesity, Fatty Liver Disease". Santa Clara, CA. 2015-05-12
Almac Group Ltd.. (5/11/15). "Press Release: Elasmogen and Almac Discovery Join Forces to Tackle Solid Tumours". 2015-05-11
Adaptimmune Therapeutics plc. (5/11/15). "Press Release: Adaptimmune Announces Closing of Initial Public Offering". Oxford & Philadelphia, PA. 2015-05-11
PhoreMost Ltd.. (5/11/15). "Press Release: PhoreMost Awarded £1.4M Innovate UK Funding to Develop Lead Oncology Programme". Cambridge. 2015-05-11
Bicycle Therapeutics Ltd.. (5/11/15). "Press Release: Appointment of Arvind Hundal as President and Chief Business Officer". Cambridge. 2015-05-11
Kymab Ltd.. (5/6/15). "Press Release: Kymab Secures US$90 Million Funding. Woodford Patient Capital Trust plc and Malin Corporation plc join the Wellcome Trust and the Bill & Melinda Gates Foundation to Complete Series B Financing". Cambridge. 2015-05-06
Selvita S.A.. (5/5/15). "Press Release: Selvita Establishes Its UK Subsidiary in Cambridge". Kraków. 2015-05-05
Sygnis AG. (5/4/15). "Press Release: Sygnis Signs Non-exclusive Distribution Agreement with Cambridge Bioscience Ltd. for UK and Ireland". Madrid & Heidelberg. 2015-05-04
Alacrita LLP. (4/28/15). "Press Release: Alacrita Expands Medical Advisory Team to Advise Clients on Clinical Strategy and Medical Due Diligence – Appoints Christine McCarthy MD as Associate Partner". London & Cambridge, MA. 2015-04-28
Omega Diagnostics Group plc. (4/27/15). "Press Release: Board Appointment. Colin King Has Agreed to Join the Board as Chief Operating Officer". 2015-04-27
AstraZeneca plc. (4/24/15). "Press Release: AstraZeneca and Innate Pharma Announce Global Co-development and Commercialisation Collaboration for IPH2201 in Immuno-oncology". 2015-04-24
BioOutsource Ltd.. (4/17/15). "Press Release: BioOutsource Ltd. Acquired by Sartorius Stedim Biotech. Takeover Expands SSB’s Service Portfolio". Glasgow. 2015-04-17
NanoTemper Technologies GmbH. (4/15/15). "Press Release: NanoTemper Technologies Inaugurates New Subsidiaries in Cambridge, UK and Krakow, Poland". 2015-04-15
Genomics plc. (4/13/15). "Press Release: Eisai and Genomics plc to Collaborate in Analyses of Large-scale Genotype / Phenotype Data to Inform Drug Development". Hatfield & Oxford. 2015-04-13
Prothena Corporation plc. (4/8/15). "Press Release: Prothena Announces Pricing of Public Offering of 3,300,000 Ordinary Shares". Dublin. 2015-04-08
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top